June 9, 2022
An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.
October 10, 2013
…the discovery of an antibody that was later found to be a useful anti-cancer drug. The patent from that discovery has since generated about $60 million in revenue for the University of California and the inventors. Another of our professors, Donald Helinski, did basic research on an enzyme in fireflies…
September 18, 2018
Researchers at University of California San Diego School of Medicine have unraveled new insights into the way cells leverage G-protein-coupled receptors (GPCRs) and their cellular waste disposal systems to control inflammation. The findings, published September 18 in Cell Reports, suggest some existing cancer drugs that inhibit these cellular activities might…
April 27, 2017
…puns about everything from antibodies to restriction enzymes, pleas to save the earth and political zingers made for a memorable day that will likely live on for months in the form of Facebook posts and internet memes. “Something that really stuck out to me was the tremendous support we saw…
December 7, 2017
…of two major monoclonal antibody drugs: Bevacizumab (marketed as Avastin), which is used to treat multiple forms of cancer, including breast, brain and colorectal, and ranibizumab (marketed as Lucentis), which treats wet age-related macular degeneration, a leading cause of blindness in the elderly. For more information on the Breakthrough Prize…
April 4, 2023
A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.
February 17, 2022
…patient’s immune system generates antibodies against sugars called sialic acids in the serum. Varki wondered how that could possibly happen since every cell in the human body is already covered with sialic acid. “That’s when I got interested in what makes humans different, on a molecular level,” Varki said. It…
September 17, 2020
…involves infusing patients with antibodies extracted from the blood of donors who have successfully recovered from COVID-19, with the hope that the resulting boost to their immune systems will shorten the length and reduce the severity of the disease. Evidence that CP therapy works is mixed, and a National Institutes…
February 7, 2020
The Protein Data Bank archive has released a new Coronavirus protease structure following the recent coronavirus outbreak, an ongoing viral epidemic primarily affecting mainland China that now threatens to spread to other parts of the world.
